Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cohen & Steers

83.51
+1.551.89%
Post-market: 83.510.00000.00%16:05 EDT
Volume:222.52K
Turnover:18.57M
Market Cap:4.26B
PE:27.31
High:83.97
Open:82.01
Low:81.76
Close:81.96
Loading ...

Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care

GlobeNewswire
·
11 Mar

BRIEF-Cohen & Steers Announces Preliminary Assets Under Management And Net Flows For February 2025

Reuters
·
11 Mar

Cohen & Steers Reports Sequential Rise in February Preliminary AUM

MT Newswires Live
·
11 Mar

Cohen & Steers Announces the Retirement of Daniel P. Charles, Head of Global Distribution

THOMSON REUTERS
·
11 Mar

Press Release: Cohen & Steers Announces the Retirement of Daniel P. Charles, Head of Global Distribution

Dow Jones
·
11 Mar

Cohen & Steers reports preliminary AUM of $88.6B as of February 28

TIPRANKS
·
11 Mar

Cohen & Steers Inc - Reports Aum of $88.6 Billion as of Feb 28

THOMSON REUTERS
·
11 Mar

Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for February 2025

THOMSON REUTERS
·
11 Mar

Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for February 2025

PR Newswire
·
11 Mar

Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company’s Single-Dose Mpox and Smallpox Vaccine Candidate

GlobeNewswire
·
10 Mar

Press Release: NLS Pharmaceutics CEO Issues Letter to Shareholders

Dow Jones
·
10 Mar

LTRN: M&A Illuminates GBM Value

Zacks Small Cap Research
·
10 Mar

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
07 Mar

Virpax Looking to Use MET to Develop Intranasal COVID Vaccine

Business Wire
·
07 Mar

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

GlobeNewswire
·
07 Mar

Plus Therapeutics Announces Peer-Reviewed Publication in Nature Communications Highlighting Promising Phase 1 Results for Rhenium (186Re) Obisbemeda in Glioblastoma

GlobeNewswire
·
07 Mar

Almirall Announces CFO Transition Plan and Appoints Jon U. Garay Alonso as CFO to Succeed Mike McClellan in August 2025

Business Wire
·
06 Mar

Plus Therapeutics Announces New Employment Inducement Grants

GlobeNewswire
·
06 Mar

Virpax’s NES100 to be Presented at The Society of Toxicology by NCATS

Business Wire
·
06 Mar

Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Thursday, March 13, 2025

GlobeNewswire
·
05 Mar